On 11/7/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 14.1%, closing at $4.29. Moreover, trading volume in this advance was above average at 128% of normal. Relative to the market the stock has been weak over the last nine months but has risen 5.4% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Marker Therapeutics has a very low Power Rating of 14 and a very low Appreciation Score of 10, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment